Elekta sell Leksell Gamma Knife® C to the U.S.

Elekta sell Leksell Gamma Knife® C to the U.S. Elekta has signed a contract with a leading hospital in the U.S. to deliver one Leksell Gamma Knife® C unit. Delivery is planned during current fiscal year. Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective and cost efficient and gentle to the patient. For further information, please contact: Håkan Bergström, CFO, Elekta AB (publ), tel. +46 8 733 342 318 Johan Sedihn, VP Elekta Neurosurgery, Elekta Instrument AB, tel. +46 8 587 254 002 ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2001/06/25/20040524BIT20690/wkr0006.pdf

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com


Documents & Links